SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-100927
Filing Date
2024-04-18
Accepted
2024-04-18 17:09:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d826835ddefa14a.htm DEFA14A 12995
  Complete submission text file 0001193125-24-100927.txt   13996
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50679 | Film No.: 24854975
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)